Amicus Therapeutics, Inc. (LON:0HF9)

Amicus Therapeutics Statistics

Total Valuation

LON:0HF9 has a market cap or net worth of GBP 1.80 billion. The enterprise value is 1.95 billion.

Market Cap	1.80B
Enterprise Value	1.95B

Important Dates

The next estimated earnings date is Wednesday, November 5, 2025.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	308.24M
Shares Outstanding	n/a
Shares Change (YoY)	+1.96%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	288.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	14.41
PS Ratio	4.31
PB Ratio	12.05
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 65.29, with an EV/FCF ratio of -54.73.

EV / Earnings	-70.27
EV / Sales	4.63
EV / EBITDA	65.29
EV / EBIT	105.57
EV / FCF	-54.73

Financial Position

The company has a current ratio of 3.21, with a Debt / Equity ratio of 2.17.

Current Ratio	3.21
Quick Ratio	2.01
Debt / Equity	2.17
Debt / EBITDA	10.95
Debt / FCF	-9.06
Interest Coverage	0.53

Financial Efficiency

Return on equity (ROE) is -22.62% and return on invested capital (ROIC) is 2.56%.

Return on Equity (ROE)	-22.62%
Return on Assets (ROA)	2.00%
Return on Invested Capital (ROIC)	2.56%
Return on Capital Employed (ROCE)	3.87%
Revenue Per Employee	835,450
Profits Per Employee	-55,724
Employee Count	499
Asset Turnover	0.73
Inventory Turnover	0.47

Taxes

In the past 12 months, LON:0HF9 has paid 11.38 million in taxes.

Income Tax	11.38M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.81% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-31.81%
50-Day Moving Average	6.83
200-Day Moving Average	7.87
Relative Strength Index (RSI)	64.14
Average Volume (20 Days)	1,717

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.71

Income Statement

In the last 12 months, LON:0HF9 had revenue of GBP 416.89 million and -27.81 million in losses. Loss per share was -0.09.

Revenue	416.89M
Gross Profit	376.72M
Operating Income	18.28M
Pretax Income	-16.43M
Net Income	-27.81M
EBITDA	24.05M
EBIT	18.28M
Loss Per Share	-0.09

Balance Sheet

The company has 168.61 million in cash and 323.58 million in debt, giving a net cash position of -154.97 million.

Cash & Cash Equivalents	168.61M
Total Debt	323.58M
Net Cash	-154.97M
Net Cash Per Share	n/a
Equity (Book Value)	149.12M
Book Value Per Share	0.48
Working Capital	270.33M

Cash Flow

In the last 12 months, operating cash flow was -33.32 million and capital expenditures -2.38 million, giving a free cash flow of -35.70 million.

Operating Cash Flow	-33.32M
Capital Expenditures	-2.38M
Free Cash Flow	-35.70M
FCF Per Share	n/a

Margins

Gross margin is 90.37%, with operating and profit margins of 4.39% and -6.67%.

Gross Margin	90.37%
Operating Margin	4.39%
Pretax Margin	-3.94%
Profit Margin	-6.67%
EBITDA Margin	5.77%
EBIT Margin	4.39%
FCF Margin	n/a

Dividends & Yields

LON:0HF9 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.96%
Shareholder Yield	n/a
Earnings Yield	-1.55%
FCF Yield	-1.99%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0HF9 has an Altman Z-Score of -0.7 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.7
Piotroski F-Score	4